The phosphorylation at Ser293, Ser300 and Ser232 residues on PDHA1 decreases PDC activity and contributes to tumour metabolic reprogramming toward glycolysis in hypoxia, by inhibiting acetyl-CoA formation and the entry in the TCA cycle [91,93–95]. Here, PDHA1 is linked to neoplasm.